This workshop is an interactive discussion on the status of the global capital market for Cannabis and Cannabiniod innovation. The panels and speakers will address the historical context, what are current issues and what lies ahead for the future so companies and technology practitioners can effectively and proactively drive global innovation in the sector.
Program Overview
Capital Markets Workshop Participants
Trevor Shewfelt, BSc, BSc Pharm, CRE
Pharmacist
Dauphin Clinic Pharmacy
VIEW BIO
Eric Berlin, J.D.
Leader of Cannabis Group
Dentons US
VIEW BIO
Hunter Land, PhD
VP, Research & Development
Biopharmaceutical Research Company
VIEW BIO
Benjamin Cameransi, MD
Managing Partner
Mingowood Pharmacal, LLC
VIEW BIO
Capital Markets Workshop Schedule
Monday, May 13th, 2024 / 8:30 AM - 11:45 AM8:30 AM - Funding Innovation in Cannabis
Charles Farkas, Loren DeFalco, Matt Daugherty
9:00 AM - Cannabis Intellectual Property: A Moving Target
Benjamin Cameransi, Kevin McKernan, Jason Moscovici
- Is the history of IP in biotechnology a good comparison for cannabis IP?
- What are the current precedents for IP in cannabis?
- What will be the role of IP in the near- and long-term future of cannabis?
9:30 AM - Perspectives on Production: Cultivation, Chemistry and More
Trevor Shewfelt, Travis Higginbotham
- Some technologies that have been proven to be valuable to cannabis cultivation
- How will cultivation be applied in the future
- Is there different/optimal ways to produce different molecules?
10:00 AM - Break
10:15 AM - Molecules, the Future of Cannabis?
Dustin Sulak, Drew Hull
10:45 AM - Implications on Cannabis Rescheduling: Now and in the Future
Hunter Land, David Traylor, Eric Berlin, Ethan Russo
- Will reschedule happen and when?
- What are the positive and negative outcomes if Cannabis is rescheduled to Schedule 3?
- Who will benefit the most and who will not benefit the most of the rescheduling to Schedule 3?
11:15 AM - Cannabis and Cannabinoids: Where to From Here?
Ethan Russo, Hunter Land, Debra Kimless, David Traylor
- What are some good examples of previous inflection points in cannabis?
- Does cannabis have more frequent inflection points and can they be planned for?
- Can the management of technology inflection points be a competitive advantage?